By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

American Thoracic Society 

1740 Broadway

New York  New York  10019  U.S.A.
Phone: 212-315-8700 Fax: 212-315-6498


SEARCH JOBS








Company News
Reviva Pharma Presented RP5063 Preclinical Efficacy Results For Pulmonary Arterial Hypertension At American Thoracic Society Conference 2016 5/20/2016 10:20:07 AM
Immunexpress Release: Septicyte LAB Outperforms Other Parameters For Distinguishing Sepsis In Data Presented At The American Thoracic Society International Conference 5/19/2016 7:54:37 AM
Xencor Reports Complete Data Results From XmAb7195 Phase 1a Trial Showing Rapid Reduction Of Serum IgE In High IgE Atopic Subjects At American Thoracic Society 2016 International Conference 5/19/2016 6:28:50 AM
New Data Demonstrating Ability Of Veracyte (VCYT)'s Genomic Test To Improve Idiopathic Pulmonary Fibrosis Diagnosis Presented At American Thoracic Society 2016 5/18/2016 7:47:06 AM
New Data Suggesting Veracyte (VCYT)'s Percepta Bronchial Genomic Classifier Can Reduce Unnecessary Invasive Procedures In Lung Cancer Diagnosis Presented At American Thoracic Society 2016 5/18/2016 7:44:23 AM
New Presentations at American Thoracic Society 2016 Reinforce OFEV (nintedanib) Efficacy, Safety And Tolerability Across Broad Range Of Patients With IPF 5/17/2016 11:35:11 AM
American Thoracic Society And Sunovion Pharmaceuticals Inc. Release Landmark Survey Of Pulmonologists’ Attitudes And Practices With Inhalation Devices For COPD At The ATS 2016 International Conference 5/16/2016 11:29:36 AM
Sunovion Pharmaceuticals Inc. Announces Health Outcomes Data On Exacerbation-Related Hospitalizations That Support The Use Of Brovana (Arformoterol Tartrate) Inhalation Solution In People With Moderate-To-Severe COPD At The 2016 American Thoracic Society Conference 5/16/2016 10:48:36 AM
Afferent Pharmaceuticals Presents Updated Positive Results With AF-219 From Phase IIB Chronic Cough Study At The 2016 American Thoracic Society International Conference 5/16/2016 10:43:27 AM
Mast Therapeutics (MSTX) Release: Positive Interim Results From Second Phase 2a Study Of AIR001 In Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) Presented At American Thoracic Society International Conference 5/16/2016 9:17:45 AM
12345678910...
//-->